EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral administration of aripiprazole to Drosophila causes intestinal toxicity

James D Hurcomb, Amrita Mukherjee, Anna E Lindell, Rebeka Popovic, Yizhou Yu, Kiran R Patil, Samantha H Y Loh, L Miguel Martins iD

Disease Models & Mechanisms · 01.03.2025 · 18 (3)

DOI: 10.1242/dmm.052180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 24.03.2025. Verfasst von James D Hurcomb und 7 weiteren Autor:innen. Beteiligte Einrichtung: MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK. Hauptthemen laut MEDLINE: Aripiprazole, Drosophila melanogaster, Intestines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, University of Cambridge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aripiprazole is a third-generation antipsychotic medication that was introduced to mitigate the poor tolerability of older antipsychotics. In contrast to the older antipsychotic drugs that act as dopamine receptor antagonists in the brain, aripiprazole functions as a partial agonist. Aripiprazole has been identified as an off-target inhibitor of mitochondrial respiratory complex I. We observed that patients prescribed aripiprazole often report gastrointestinal disturbances, but the mechanism underlying these side effects is not clear. We modelled the potential mitochondrial toxicity of aripiprazole in the gastrointestinal system using the fruit fly (Drosophila melanogaster). Aripiprazole consumption impaired Drosophila gut function and faecal output. It also reduced the mitochondrial membrane potential and increased reactive oxygen species (ROS) levels in intestinal cells. ROS activate the c-Jun N-terminal kinase (JNK) pathway, which induces cellular stress and cell death. Aripiprazole increased JNK activation in the intestinal cells of flies, resulting in cell death, which was suppressed by antioxidants. We conclude that aripiprazole activates the JNK pathway of cell death via mitochondrial ROS production. Using antioxidant supplements may help reduce aripiprazole-induced toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AripiprazoleDrosophila melanogasterIntestinesAnimalsReactive Oxygen SpeciesAdministration, OralMitochondriaMembrane Potential, MitochondrialJNK Mitogen-Activated Protein KinasesCell DeathAntioxidants

Stichwörter der Autor:innen

DrosophilaAntipsychoticsAripiprazoleIntestineJNK signallingMitochondriaMitochondrial respiratory complex IReactive oxygen species

Substanzen

AripiprazoleReactive Oxygen SpeciesJNK Mitogen-Activated Protein KinasesAntioxidants

Autor:innen und Institutionen

  • MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.

ORCID-Profile: L Miguel Martins

Förderung

  • Medical Research Council
  • University of Cambridge

Zitieren

APA

Hurcomb, J. D., Mukherjee, A., Lindell, A. E., Popovic, R., Yu, Y., Patil, K. R., Loh, S. H. Y., & Martins, L. M. (2025). Oral administration of aripiprazole to Drosophila causes intestinal toxicity. Disease Models & Mechanisms, 18(3). https://doi.org/10.1242/dmm.052180

Vancouver

Hurcomb JD, Mukherjee A, Lindell AE, Popovic R, Yu Y, Patil KR, et al. Oral administration of aripiprazole to Drosophila causes intestinal toxicity. Disease Models & Mechanisms. 2025;18(3). doi:10.1242/dmm.052180

BibTeX
@article{Hurcomb2025,
  author = {Hurcomb, James D and Mukherjee, Amrita and Lindell, Anna E and Popovic, Rebeka and Yu, Yizhou and Patil, Kiran R and Loh, Samantha H Y and Martins, L Miguel},
  title = {Oral administration of aripiprazole to Drosophila causes intestinal toxicity},
  journal = {Disease Models & Mechanisms},
  year = {2025},
  volume = {18},
  number = {3},
  doi = {10.1242/dmm.052180}
}
Kostenlos starten →